Sanofi is trading at $47.31, up 4.37%, amid a healthcare-sector rally following the Democratic midterm sweep.
- Broader markets also advanced as election uncertainty eased.
- A November 4 report said Sanofi’s rebound continued after its October 30 results and raised 2026 targets, but identified no new company-specific catalyst for today’s move.
- Listed partnership and program-discontinuation news do not clearly explain the gain.